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Abstract
Bacground: Resilience has been defined as the capacity or the ability to rebound from and positively adapt to
significant stressors, despite experiences of significant adversity or trauma. To capture to what extent an individual
copes with stress in a resilient fashion the Brief Resilient Coping Scale (BRCS) was developed. This tool was
validated in people with chronic disease, such as rheumatoid arthritis using standard psychometric techniques of
classical test theory, but not yet in patients with Systemic lupus erythematosus (SLE). The aim of this study was to
explore the psychometric properties of the Brief Resilient Coping Scale in patients with SLE using Rasch analysis.
Method: This study used cross-sectional data. The BRCS was administered to 232 patients with systemic lupus
erythematosus. The aspects analyzed were unidimensionality, local independence and differential item functioning
(DIF) to construct an interpretative scale of scores with the Rasch model.
Results: Rating scale mode (RSM) showed that the four categories used in the items of the BRCS are properly
ordered. The four items provided a good fit to the polytomous Rasch model. Moreover, the parameters were
sufficiently separated to measure resilience in patients with SLE. BRCS is a unidimensional scale (eigenvalue = 1.843)
of resilience and the items were locally independent. There was no DIF between males and females in the sample.
Only marginally significant differences depending on the level of education were found. The BRCS showed
adequate discriminant validity between groups of scores.
Conclusions: BRCS is a suitable scale for measuring resilience in patients with SLE. This scale might be useful for
clinicians to obtain information concerning the degree of resilience that each patient has, allowing individuals
with low resilience to be identified who need interventions aimed at developing coping skills.
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Background
Systemic lupus erythematosus (SLE) is a chronic auto-
immune rheumatic disease, characterized by widespread
inflammation of blood vessels and connective tissue [1].
The severity of symptoms, the secondary effects of medi-
cation, its unpredictability and early onset along with the
chronic evolution of the disease are stress factors that
provoke medium and long term psychological disorders
in many sufferers [2, 3]. Such orders include anxiety and
depression [4–7].
These may undermine the adaptation capacity of the
patient, and their ability to maintain or regain mental
health. This capacity of adaptation or facing up to the
disease will largely depend on the patient’s psychological
capacity, upon which is based the concept of resilience,
which has been defined as the capacity or the ability
to rebound from and positively adapt to significant
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stressors [8, 9], despite experiences of significant ad-
versity or trauma [10].
Resilience was originally used in the field of physics
to refer to the capacity of a material or systems to re-
turn to equilibrium after displacement, and has been
adapted and developed in psychology as a theoretical
construct of mental health protection, promotion and
recovery processes [11]. Currently, this concept is
increasingly used in the area of clinical medicine, es-
pecially, in patients with chronic diseases. Further-
more, some scientific research focuses on the role of
resilience in chronic patients’ adaptation to their dis-
ease [12–14].
In this sense, in certain chronic diseases, such as can-
cer or Parkinson’s, patients with high levels of resilience
have a better functional capacity, higher stability and
better adaptation to their social environment. Also, the
clinical symptomatology of these subjects is less severe,
their pain threshold is higher, and they are less tired and
are less likely to suffer from anxiety and depression,
which leads to a better life quality [15, 16].
Because of this, evaluation of the degree of resilience
is very important in subjects with chronic disease such
as SLE, enabling deficit situations to be detected and im-
proved [17, 18].
Resilience has been assessed mainly through self-
report measures such as the Brief Resilient Coping Scale
(BCRS), a 4-item measure that has been validated for
people with rheumatoid arthritis, university students and
ageing persons [19–21] using standard psychometric
techniques of classical test theory. However, until now
this scale has not been validated for people with SLE,
nor has its psychometric properties been evaluated by
item response theory [22].
For this reason, the aim of the present paper is to val-
idate the Brief Resilient Coping Scale in patients with
SLE using the Rasch model, testing unidimensionality,
local independence, differential item functioning (DIF),
and constructing an interpretative scale of scores ob-
tained with the fitted model.
Methods
Participants and procedure
A cross-sectional study was developed in the province of
Murcia (south-eastern Spain) with patients who met the
revised American College of Rheumatology classification
criteria for SLE diagnosis [23]. The BRCS and EQ-5D
scales were administered, from July to August 2014, by
postal survey to 450 eligible subjects selected randomly
from the rare disease database of the Murcia Health
Service. The study conforms to the principles of the
Declaration of Helsinki [24] and was approved by the
Research Bioethics Committee of the University of
Murcia (Spain) (ID 1204/2015; 4/11/2015).
Instruments
The Brief Resilient Coping Scale (BRCS) is a 4-item, uni-
dimensional outcome measure designed to capture to
what extent an individual copes with stress in a resilient
fashion. In the original version, the items have a re-
sponse format with five options, where 1 means the
statement “does not describe you at all” and 5 means “it
describes you very well”, but in this work the number of
categories was reduced to four because the central
category was removed to force decision-making of pa-
tients (Appendix). The BRCS meets the minimal stand-
ard for reliability and validity of a resilience instrument.
In this study, the internal consistency coefficient was
0.82 and the Spearman-Brown coefficient was 0.81. The
concurrent validity coefficient for BRCS was 0.34 with
EQ-5D and 0.34 with EQ-VAS.
The EuroQol (EQ-5D) is a generic health index which
comprises a five-part questionnaire (mobility, self-care,
usual activities, pain/discomfort, anxiety/depression) to
calculate a ‘utility’ or health index value between “0” and
“1”, and a visual analogue self-rating scale (EQ-VAS)
which ranges from 0 (minimum score) to 100 (maximum
score). The EQ-5D is a reliable and valid instrument for
measure quality of life [25, 26].
Rasch analysis
The Rasch family of models transforms ordinal scores to
interval scales (logits) [27]. For this it is necessary to
specify a model according to the structure of the items
in the scale. If the data fit the model specified, then in-
dependent item and ability parameters will be estimated.
Also, applying the Rasch model involves evaluating the
order of the item categories, fitting of the items, the
separability of the parameters, and DIF. If all the ana-
lyses indicate that the scale forms a unidimensional rule
of resilience, it will be possible to construct a more
interpretative transformed scale.
There are two models in the Rasch family of models
to estimate the location parameters of the items: the par-
tial credit model (PCM) [28] and the rating scale model
(RSM) [29]. Both models determine the parameters of
the transitions between the categories of the items, but
PCM allows each item to have a different unordered
threshold, while RSM permits equal transitions between
categories for each item. Therefore, a first evaluation of
the appropriate model to explain the BRCS results
involves examining whether the average score of the
people who have answered each category in each item
increases monotonically. A second evaluation involves
comparing the fit in both models with the deviance (G2)
which follows an approximately normal distribution with
df equal to the difference between the free parameters
estimated in each of the models. If the difference
between deviances in both models is not significant at
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p < .05, then the simplest model is selected to explain
the matrix of responses to the BRCS.
To estimate the parameters of the Rasch models Con-
Quest v. 3.0 [30] was used, and for descriptive statistics
and convergent validity we used SPSS v. 19.0.
Item fit
To assess the goodness of fit of the data to the Rasch
model Conquest uses two statistics based on residuals of
mean square (MNSQ). The unweighted mean square de-
tect unexpected responses pattern when ability param-
eter is far to the item location parameter, while weighted
mean square detect unexpected responses when ability
parameter is very close to the item location parameter.
An item shows a good fit to Rasch models if the un-
weighted or weighted item fit is found in the interval 0.6
to 1.4 [31].
Reliability
Conquest also provides a separability coefficient of the
parameters that makes it possible to evaluate whether
the localization parameters of the items are sufficiently
separate to cover the whole interval of the ability. In this
case, the parameters are separate enough if the reliability
coefficient is equal to or higher than 0.90 or χ2 is
significant.
Unidimensionality and local independence
In the Rasch model the items must form a unidimen-
sional scale. Unidimensionality was tested with a princi-
pal components analysis (PCA) of residuals. It was
considered that the BRCS was unidimensional if at least
the first principal component explained a 50 % of the
variance and the eigenvalue was higher than 1.5. Local
independence was examined with inter-item residual
correlation matrix. The items were locally independent if
inter-item residual correlations was lower than 0.70.
DIF
DIF is evidence that the probabilities of the response of
the groups can vary through the continuum of ability.
Therefore, DIF exists if a group has a higher probability
of offering an answer rather than another one systemat-
ically though all the levels of ability. In the present study
DIF has been tested with regard to gender, a difference
between male and female no greater than 0.50 has been
taken as a criterion of non-DIF [32].
Wright map
A Wright map [27] allows ability parameters to be com-
pared with item localization parameters on the BRCS in
terms of logits. The Wright map to assess whether the
calibration sample is appropriate for the group of items
selected and has been useful or not. In both cases, this
imbalance would cast doubt on the results of the calibra-
tion of the scale.
Differences between groups
After fitting the data to the Rasch model, the differences
in resilience as regards gender, education and age inter-
val were determined by Student’s t test or ANOVA, de-
pending on the number of levels of each independent
variable. Statistical significance was taken as p < 0.05.
Convergent validity
To explore convergent validity we hypothesized that
resilience would be higher among those SLE patients
who have a greater quality of life, as shown by literature
studies [33–35]. Subjects were first divided into 3 cat-
egories (low, moderate, high) using tertiles of HRQoL
level as cut-off points. We then used ANOVA followed
by the MSD post hoc test to compare mean scores from
the BRCS across these 3 categories as a way to infer
discriminant ability regarding HRQoL.
Results
Age, gender, disease duration, educational level and
comorbidity with other illness in the sample appear in
Table 1. The sample consisted of 232 cases (88.2 % fe-
males) who returned their postal survey, a response rate
of 51.5 %. The average age was 48.6 years (SD = 13.3)
Table 1 Patients’ characteristics (N = 232)
Mean (SD) N(%)
Age (years) 48.6(13.3)
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and the average duration of the illness was 15.9 years
(SD = 9.1).
Ordering of categories
Table 2 shows the mean and typical deviation of the item
scores regarding the categories. The gradual increase of
the means in each category signifies that the categories are
well ordered and no unexpected violations have occurred.
Which model is better?
Which is the best model to explain the response matrix
was tested by comparing deviance of PCM vs. RSM.
Deviance for PCM was 1954.767 with df = 13, and for
RSM was 1957.619 with df = 7. The difference was 2.852
(df = 6), which was not statistically significant (p > 0.05).
So, RSM was chosen as the most appropriate model for
the BRCS. The location parameters appear in Table 3.
As expected from a scale constructed based on the
classic test model, the four items had high homogeneity
(0.83 to 0.87) and the localization parameters were very
close to the mean resilience of the sample used during
the study. Items 2 and 3 were indicative of high resilience,
while items 1 and 4 were below average parameters. The
thresholds between categories were in order and suffi-
ciently separated, indicating that they fulfilled their ex-
pected function of representing the degree of resilience in
this sample, as shown in the Wright map (Fig. 1).
Item fit
Both the unweighted and weighted mean square for the
items and the categories were in the specified interval
[0.6, 1.4], so it is safe to say that the responses on the
BRCS scale follow the RSM (Table 3).
Separation reliability coefficient
The separation coefficient of the parameters was .98
(χ2 = 112.3, df = 3, p < 0.001), which indicates that the
thresholds of the four items were able to cover the
Table 2 Frequencies(%) distribution for each item of the Brief Resilient Coping Scale
Categories
Item 0 1 2 3
I look for creative ways to alter difficult situations. 19(8.3 %) 55(24.1 %) 78(34.2 %) 76(33.3 %)
Average score within category 1.47 4.53 7.18 10.34
SD Score within category 1.58 1.64 1.62 1.54
Regardless of what happens to me, I believe I can control my reaction to it. 39(17.1 %) 69(30.3 %) 78(34.2 %) 42(18.4 %)
Average score within of category 2.87 5.51 8.71 10.76
SD Score within of category 2.03 1.86 1.64 1.56
I believe i can grow in positive ways by dealing with difficult situations 28(12.3 %) 65(28.5 %) 82(35.9 %) 53(23.3 %)
Average score within of category 2.00 5.38 7.83 10.85
SD Score within of category 1.66 1.83 1.70 1.42
I actively look for ways to replace the losses I encounter in life. 16(7.0 %) 49(21.5 %) 93(40.8 %) 70(30.7 %)
Average score within of category 1.75 4.35 7.01 10.43
SD Score within of category 2.24 1.83 1.87 1.57
Table 3 Parameters of location and fitting statistics for the items and thresholds parameters of the Brief Resilient Coping Scale
Unweighted fit Weighted fit
Item Location parameter Standard error RjX MNSQ CI T MNSQ CI T
1 −0.431 0.082 .87 0.87 [0.82, 1.18] −1.4 0.95 [0.81–1.19] −0.6
2 0.706 0.081 .83 1.11 [0.82, 1.18] 1.2 1.09 [0.82, 1.18] 0.9
3 0.237 0.081 .85 0.94 [0.82, 1.18] −0.6 0.96 [0.82, 1.18] −0.5
4 −0.512a 0.141 .83 0.98 [0.82, 1.18] −0.1 1.01 [0.81, 1.19] 0.1
Categories
0 0.94 [0.82, 1.18] −0.7 1.11 [0.70, 1.30] 0.7
1 −2.30 0.083 1.24 [0.82, 1.18] 2.4 1.23 [0.80, 1.20] 2.1
2 −0.81 0.077 1.25 [0.82, 1.18] 2.5 1.27 [0.82, 1.18] 2.7
3 2.39a 1.12 [0.82, 1.18] 1.3 1.16 [0.77, 1.23] 1.3
Notes: athe parameter is constrained, RjX item-test corrected correlation, MNSQ Mean square, CI Confidence Interval, T Transformation Wilson-Hilferty
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interval of resilience of the sample in which the scale
was calibrated, in spite of the small number of items
of the BRCS.
Dimensionality and local independence
Dimensionality of the BRCS was tested with a residual
PCA. The small number of items of the scale prevented
the first factor from obtaining the expected salience as
in other larger scales, but the first main component
explained 46.08 % of total variance (eigenvalue = 1.843) so
the scale was considered to be essentially unidimensional.
Local independence was obtained through correlations
of the standardised residuals of the items which varied
between −0.06 and −0.49, never reaching the limit of
0.70, so that the responses to the items were also consid-
ered to be locally independent.
DIF
The difference between males and females in the
localization parameters of the four items was 0.11,
never surpassing 0.50, so DIF was not significant for
any item.
Fig. 1 Wright map for BRCS
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Differences between groups
After fitting the BRCS to RSM, the resilience parameters
for the sample were estimated. No significant differences
were found with respect to gender or age interval, but
marginally significant differences (p = .061) were found
between educational levels, the mean of the resilience
parameters increasing with educational level. Thus, the
group of patients who had only studied primary educa-
tion obtained a mean of resilience of 0.146 (SD = 2.69),
while those who had received higher education obtained
a mean of 1.307 (SD = 2.40) (Table 4).
Convergent validity
Table 5 presents the BRCS scores by HRQoL level.
Scores increased significantly with increasing either EQ-
5D or EQ-VAS levels. The mean score obtained by the
group of patients with a high level of EQ-VAS (60.2 to
100) was 69.7, which is 39.4 % per cent higher than the
low-level category (p < 0.001), these differences were also
observed when comparison between extreme groups was
made using the “utility” values obtained by means of
EQ-5D (41.2 %) providing, in both cases, evidence of the
construct validity of the BRCS.
Discussion
This is the first study that gives evidence of the reliabil-
ity and validity of the BCRS using Rasch analysis, in a
sample of patients with SLE. Good support was estab-
lished for the psychometric properties of the BRCS with
a good fit to the RSM, and no DIF was found. There was
good internal consistency and support for the unidimen-
sionality and local independence of the items on the
scale. These results are in agreement with other pro-
duced with classical test theory [19–21].
The studies made to date in which resilient coping has
been studied in patients with SLE have used the resilience
scale (RS) [36, 37]. This scale has 25 items and was devel-
oped for the general population. However, the brevity of
the BCRS allows it to be completed quickly and easily by
patients with conditions such as SLE, and that it can be
administered multiple times in longitudinal studies as well
as in large surveys. Validation of this scale using the Rasch
model also points to its potential usefulness in daily clin-
ical practice in patients with systematic erythematosus
lupus.
Study of the dimensionality showed that the BRCS
forms a unidimensional scale with localization parame-
ters of the items and thresholds of the categories which
clearly separate the resilience of the evaluated patients.
There was no evidence of local dependence in the an-
swers to the items.
This scale reflects one of the patterns of resilience,
more specifically the situational pattern, which corre-
sponds to resilient coping patterns [10]. Items in this
measure refer to tenacity, optimism, creativity, and ag-
gressive approach to problem solving, and commitment
to positive growth from difficult situations [19]. By ad-
ministering this scale to the patients, we obtain informa-
tion concerning the degree of resilience that each
patient has, allowing individuals with low resilience to
be identified who need interventions aimed at develop-
ing coping skills. In this way, patients who receive treat-
ment will develop abilities to face stressing situations
daily, lessening the possibility of a psychological crisis.
In fact, in the study of Sinclair & Wallston [19] where
BRCS was validated in a sample of rheumatoid arthritis
in the US, it was observed that resilient coping showed
significant improvement after a cognitive-behavioral
intervention designed to enhance adaptive coping, which
indicates that levels of resilient coping can be improved.
Table 4 Differences between groups (Student’s t /ANOVA)
Mean (SD) t/F df P
Gender
Male 1.28 (2.07) 1.10 226 0.271
Female 0.74 (2.39)
Educational level
No schooling 0.15 (2.69) 2.50 (3, 226) 0.061a
Primary education 0.40 (2.40)
Secundary education 1.01 (2.08)
Higher education 1.31 (2.40)
Age Interval
1 (<45 años) 0.93 (2.36) .22 (2, 226) 0.800
2 (45–65 años) 0.75 (2.22)
3 (>65 años) 0.63 (2.70)
aMarginally significant
Table 5 Convergent validity of the Brief Resilient Scale (BRCS)
regarding HRQol (Euroqol test)a
BRCS Scores
n Mean [0–100] (CI 95 %)
EQ visual analogue scale (EQ-VAS)Tertiles
Low (T1) [≤40.0] 75 50.9 (45.2-56.6)
Moderate (T2) [40.1–60.1] 66 60.1 (54.1-66.1)
High (T3) [60.2–100.0] 69 69.7 (62.9-76.5)
Overall mean 210 60.0 (56.3-63.7)
EQ-5D descriptive system Tertiles
Low (T1) [≤0.08] 75 49.1 (43.5-54.7)
Moderate (T2) [0.08–0.31] 77 60.2 (54.2-66.2)
High (T3) [0.32–1.00] 73 69.5 (63.3-75.7)
Overall mean 225 59.5 (55.9-63.1)
aOne-way analysis of variance followed by post hoc test. EQ EuroQol, EQ-VAS:
Ho: T1 vs T2= > p = 0.03; Ho: T1 vs T3= > <0.001: Ho: T2 vs T3= > p = 0.03. EQ-5D:
Ho: T1 vs T2= > p = 0.009; Ho: T1 vs T3= > <0.001: Ho: T2 vs T3= > p = 0.02
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In addition the BRCS correlates with perceived health
status in patients with SLE, providing evidence of its
construct validity. If interventions to build resilient cop-
ing could be refined, then perhaps quality of life could
be improved in this population with a stressful chronic
condition. The improvement of the quality of life in an
incurable chronic illness is a primary objective and very
important for patients. It would be advisable to consider
cognitive-behavioral interventions aimed at enhancing
resilient coping as a no-pharmacological treatment im-
portant for patients with SLE. This recommendation has
been suggested in a study with Parkinson’s patients,
where resilient coping is considered one of the deter-
mining factors of disability and quality of life [16].
The length of the scale, only 4 items, may be consid-
ered a limiting factor of the quality of the scores, al-
though its brevity means it can be used in clinical
contexts where patients might not answer other longer
resilience scales (“short but sweet”).
Future research will study the properties of the BRCS
in other clinical samples with chronic (e.g., fibromyalgia,
diabetes, atopic dermatitis) or degenerative disease (e.g.,
Parkinson’s disease, Multiple sclerosis).
Conclusions
The BRCS is a suitable scale for measuring resilience in
patients with SLE. This scale might be useful for clini-
cians can obtain information concerning the degree of
resilience that each patient has, allowing individuals with
low resilience to be identified who need interventions
aimed at developing coping skills.
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